Abstract:Objective: Existing research suggests that bone marrow-derived mesenchymal stem cells (BMSCs) may promote endogenous bone repair. This may be through the secretion of factors that stimulate repair processes or directly through differentiation into osteoblast-progenitor cells. However, the osteogenic potential of BMSCs varies among different tissue sources (e.g., mandibular versus long BMSCs). The main aim of this study was to investigate the difference in osteogenic differentiation capacity between mandibular BMSCs (mBMSCs) and tibial BMSCs (tBMSCs). Materials and Methods: Bioinformatics analysis of the GSE81430 dataset taken from the Gene Expression Omnibus (GEO) database was performed using GEO2R. BMSCs were isolated from mandibular and tibial bone marrow tissue samples. Healthy pigs (n = 3) (registered at the State Office for Nature, Environment, and Consumer Protection, North Rhine-Westphalia (LANUV) 81-02.04.2020.A215) were used for this purpose. Cell morphology and osteogenic differentiation were evaluated in mBMSCs and tBMSCs. The expression levels of toll-like receptor 4 (TLR4) and nuclear transcription factor κB (NF-κB) were analyzed using quantitative polymerase chain reaction (qPCR) and Western blot (WB), respectively. In addition, mBMSC-derived extracellular vesicles (mBMSC-EVs) were gained and used as osteogenic stimuli for tBMSCs. Cell morphology and osteogenic differentiation capacity were assessed after mBMSC-EV stimulation. Results: Bioinformatic analysis indicated that the difference in the activation of the TLR4/NF-κB pathway was more pronounced compared to all other examined genes. Specifically, this demonstrated significant downregulation, whereas only 5–7 upregulated genes displayed significant variances. The mBMSC group showed stronger osteogenic differentiation capacity compared to the tBMSC group, confirmed via ALP, ARS, and von Kossa staining. Furthermore, qPCR and WB analysis revealed a significant decrease in the expression of the TLR4/NF-κB pathway in the mBMSC group compared to the tBMSC group (TLR4 fold changes: mBMSCs vs. tBMSCs p < 0.05; NF-κB fold changes: mBMSCs vs. tBMSCs p < 0.05). The osteogenic differentiation capacity was enhanced, and qPCR and WB analysis revealed a significant decrease in the expression of TLR4 and NF-κB in the tBMSC group with mBMSC-EVs added compared to tBMSCs alone (TLR4 fold changes: p < 0.05; NF-κB fold changes: p < 0.05). Conclusion: Our results indicate that mBMSC-EVs can promote the osteogenic differentiation of tBMSCs in vitro. The results also provide insights into the osteogenic mechanism of mBMSCs via TLR4/NF-κB signaling pathway activation. This discovery promises a fresh perspective on the treatment of bone fractures or malunions, potentially offering a novel therapeutic method.

6-Bromoindirubin-3’-oxime Promotes Osteogenic Differentiation of Canine BMSCs Through Inhibition of GSK3β Activity and Activation of the Wnt/β-catenin Signaling Pathway

The Effect of Rhbmp-2 on Canine Osteoblasts Seeded Onto 3d Bioactive Polycaprolactone Scaffolds

Resveratrol Promotes Osteogenic Differentiation of Canine Bone Marrow Mesenchymal Stem Cells Through Wnt/Beta-Catenin Signaling Pathway

6-Bromoindirubin-3-oxime Promotes Osteogenic Differentiation of Periodontal Ligament Stem Cells and Facilitates Bone Regeneration in a Mouse Periodontitis Model

Biological effects of different concentrations of recombinant human bone morphogenetic protein-2 and basic fibroblast growth factor on bone marrow stromal cells from dogs

Ginkgo biloba extract promotes osteogenic differentiation of human bone marrow mesenchymal stem cells in a pathway involving Wnt/β-catenin signaling

Isolation and Culture of Dog (canis Lupus) BMSCs and Its Osteoblast Differentiation Potential in Vitro

[The effect of icariin and astragalosid I on the proliferation and differentiation of bone marrow stromal cells]

Effects of Bionic Microstructure Artificial Bone on Dog Bone Marrow Stromal Cells: an in Vitro Study

Influence of Bone Morphogenetic Protein Microspheres on the Proliferation and the Expression of Marrow Stromal Cell of Canine

BMP-2 Gene Modified Canine bMSCs Promote Ectopic Bone Formation Mediated by a Nonviral PEI Derivative

Osteogenic Potentiality of Cultured Dogs Marrow Stromal Cells under Condition of Bone Induction

Influence of recombinant human bone morphogenetic protein-2 loaded microspheres combined with fibrin glue on the proliferation and differentiation of canine bone marrow stromal cells

Experimental Study of Dog Bone Marrow Stromal Cells Induced into Osteoblasts

Effect of Naringin on Proliferation and Osteogenic Differentiation of Bone Marrow Stromal Cells in Vitro

Porcine Mandibular Bone Marrow-Derived Mesenchymal Stem Cell (BMSC)-Derived Extracellular Vesicles Can Promote the Osteogenic Differentiation Capacity of Porcine Tibial-Derived BMSCs

IGF-1 Induces Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells by Promoting SOX4 via the MAPK/ERK Pathway

Transcriptome Analysis of the Transdifferentiation of Canine BMSCs into Insulin Producing Cells

Study on Culture of Bone Marrow Stromal Cell in Vitro and Its Osteogenic Potential

Notoginsenoside R1 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells via ERα/GSK‐3β/β‐catenin signalling pathway

β-mercaptoethanol promotes osteogenesis of human mesenchymal stem cells via sirt1-ERK pathway